Stempoint Capital’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-222,253	Closed	-$8.08M	–	58
2024 Q1	$8.08M	Buy	222,253 +191,263	+617%	+$6.95M	2.14%	15
2023 Q4	$628K	Buy	+30,990	New	+$628K	0.17%	54